Quest Diagnostics (DGX) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter declined slightly compared to the immediately preceding period, while exceeding the level of the same period one year earlier. The full-year trailing revenue total reflected continued growth from prior periods.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter declined slightly compared to the immediately preceding period, while exceeding the level of the same period one year earlier. The full-year trailing revenue total reflected continued growth from prior periods.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.8B
Revenue reported for this quarter.
Quarter-over-quarter
-0.4%
Change from the immediately preceding quarter.
Year-over-year
+7.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$11B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $2.7B | +12.1% |
| Jun 30, 2025 | $2.8B | +15.2% |
| Sep 30, 2025 | $2.8B | +13.2% |
| Dec 31, 2025 | $2.8B | +7.1% |
Revenue performance
The reported revenue direction was a modest decrease from the prior quarter, contrasting with the growth seen in the prior quarter compared to earlier periods.
Quarterly comparison
When compared with the immediately preceding quarter, revenue edged lower. However, against the same quarter one year earlier, revenue was higher.
What to watch
The decreased cash and cash equivalents balance at period end merits attention, though operating cash flow improved year over year.